Evonik Q2 adjusted EBITDA rises 24% to €630 million

PUBT · 2d ago
Evonik Q2 adjusted EBITDA rises 24% to €630 million
  • Evonik posted Q2 adjusted EBITDA up 24% to EUR 630 million, citing higher volumes and selling prices amid supply-chain bottlenecks.
  • Revenue climbed 11%, while net income fell to EUR 84 million; free cash flow improved to EUR 49 million.
  • Advanced Technologies adjusted EBITDA rose 25% to EUR 333 million, lifting margin 2.6 percentage points to 20.2%.
  • Custom Solutions adjusted EBITDA increased 7% to EUR 271 million, with margin up 0.5 percentage points to 19.1%.
  • Evonik raised its 2026 adjusted EBITDA outlook to EUR 2.0 billion-EUR 2.2 billion and extended its efficiency program with 3,200 more job cuts for 2027-2029.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Evonik Industries AG published the original content used to generate this news brief on August 04, 2026, and is solely responsible for the information contained therein.